Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Healthia expands in Queensland and Tasmania with attractive clinic acquisitions

  • In News
  • July 5, 2021
  • Alfred Chan
Healthia expands in Queensland and Tasmania with attractive clinic acquisitions

It hasn’t taken long for allied healthcare operator Healthia (ASX: HLA) to get the ball rolling in the new financial year, acquiring three new businesses in Queensland and Tasmania under their annual commitment to deploy $20m towards growth each year. 

The acquisitions include two optometry businesses in North Queensland and one physiotherapy clinic in Tasmania. Between them, the three businesses are expected to contribute $2.2 million in revenue towards Healthia and $0.39m EBITDA. 

Acquired for $1.48m by Australia’s fastest growing allied health company, they enter the Healthia network at an attractive 3.8x EBITDA multiple for shareholders given the average previously has been around 4.2x.

Although Healthia exceeded last year’s $20m acquisition commitment, primarily through their $43m acquisition of The Optical Company and its 41 optometry businesses, the company maintained discussions with prospective clinics. This has provided a handy pipeline of acquisitions to choose from over the coming months under their annual commitment budget. 

“While we have been integrating the 41 acquired clinics onto Healthia’s national platform and support system, we have had keen interest from external optometry businesses enquiring about joining the Healthia network,” said Healthia CEO, Wesley Coote.  

Through their acquisition of the Optical Company in October 2020, Healthia entered a new allied health market that opened up opportunities to target optometry and audiology businesses which generate $3.3 billion in annual revenue. The market is driven by the 13.2 million residents that suffer from a form of permanent eye disease as well as Australia’s aging population. It does, however, continue Healthia’s hugely successful model of consolidating fragmented industries where Specsavers and OPSM account for less than 25% of the 3,200 optometry businesses in Australia. 

Now with more than 200 allied health businesses around Australia, clinic owners have been keen to join the Healthia network and capitalise on the marketing and support services. These services offered to clinics within the network were the drivers behind 14.5% organic growth for the Company in the Half Year ended 31 December 2020. 

Since listing on the ASX in 2018, Healthia has gone from strength-to-strength with its underlying EBITDA up 91% to $11m for the Half Year, and Full Year results expected in August. 

Keen to grow their business with Healthia’s industry-leading education and support services, clinic owners have been particularly interested in Healthia’s clinic class share program. This provides clinic owners with an equity stake in the success of their clinics while alleviating themselves of mundane back office duties that hamper small business productivity. 

Having taken just a small bite of the $20m annual acquisition spend through these three new businesses, Healthia is well positioned for growth at a time when Australians are prioritising their health more than ever. 


*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.